[CAS NO. 484-78-6]  3-Hydroxykynurenine

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [484-78-6]

Distributor
Catalog
AS233089
Brand
Arctom Scientific
CAS
484-78-6

DESCRIPTION [484-78-6]

Overview

MDLMFCD00047832
Molecular Weight224.21
Molecular FormulaC10H12N2O4
SMILESO=C(O)C(N)CC(C1=CC=CC(O)=C1N)=O

For research use only. We do not sell to patients.

Summary

3-Hydroxykynurenine, a metabolite of tryptophan, is a potential endogenous neurotoxin whose increased levels have been described in several neurodegenerative disorders. 3-Hydroxykynurenine induces neuronal apoptosis [1] .


IC50 & Target

Human Endogenous Metabolite


In Vitro

3-Hydroxykynurenine-induced neuronal cell death shows several features of apoptosis [1] .
3-Hydroxykynurenine is a metabolic intermediate of the kynurenine pathway, the major metabolic pathway of tryptophan (Trp) [1] .
3-Hydroxykynurenine acts as an endogenous neurotoxin in the brain under pathological conditions [1] .
3-Hydroxykynurenine (20-100 μM) significantly inhibits CD4 + T-cell proliferation in a dose-dependent manner with IC 50 of approximately 70 μM [2] .
3-Hydroxykynurenine (20-100 μM) induces significant CD4 + T-cell-mediated cell death in a dose-dependent manner [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay [2]

Cell Line: CD3/CD28 bead-stimulated CD4 + T cells
Concentration: 0, 20, 40, 60, 80, and 100 μM
Incubation Time: 72 hours
Result: Significantly inhibited CD4 + T-cell proliferation in a dose-dependent manner with an IC 50 of approximately 70 μM.

In Vivo

3-Hydroxykynurenine administration (560 mg/kg IP on a daily basis on days 1 to 7, days 7 to 14, or days 1 to 14) results in significant prolongation of graft survival whether administered between days 1 to 7, days 7 to 14, or days 1 to 14 [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c (H2d) mice [2]
Dosage: 560 mg/kg
Administration: IP injection
Result: There was significant prolongation of graft survival in all treatment groups in comparison to the controls.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

1M HCl : 33.33 mg/mL ( 148.66 mM ; ultrasonic and adjust pH to 1 with HCl)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.4601 mL 22.3005 mL 44.6010 mL
5 mM 0.8920 mL 4.4601 mL 8.9202 mL
10 mM 0.4460 mL 2.2301 mL 4.4601 mL
* Please refer to the solubility information to select the appropriate solvent.


Synonyms

Benzenebutanoic acid, α,2-diamino-3-hydroxy-γ-oxo-
Alanine, 3-(3-hydroxyanthraniloyl)-
α,2-Diamino-3-hydroxy-γ-oxobenzenebutanoic acid
Hydroxykynurenine
3-Hydroxykynurenine
3-Hydroxy-DL-kynurenine
DL-3-Hydroxykynurenine
2-Amino-4-(2-amino-3-hydroxyphenyl)-4-oxobutanoicacid